NeoGenomics Laboratories Inc.

About NeoGenomics Laboratories Inc.

NeoGenomics Laboratories is a cancer-focused diagnostics company providing comprehensive oncology testing services to pathologists, oncologists, hospitals, and biopharmaceutical firms. Its laboratories perform molecular, cytogenetic, flow cytometry, and immunohistochemistry assays that guide precision therapy and clinical trial selection. Operating CLIA-certified and CAP-accredited facilities across the United States, the company supports community pathology practices, academic centers, and pharmaceutical sponsors with expedited turnaround, expert consultation, and data integration tools. NeoGenomics also offers biopharma services encompassing biomarker discovery, companion diagnostic development, and clinical trial logistics, aiming to accelerate targeted cancer treatment and improve patient outcomes through high-quality, standardized laboratory testing.